Impact Dashboard - 2014 By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert 198.7 million DALYs, and 56.4% of the SP target to provide 105.6 million CYPs; with 56.7% elapsed time. 12 African countries have averted > 1 million DALYs in 2014, accounting for 88% YTD total, see page 3. As a region, West & Central Africa has doubled DALYs averted relative to YTD 2013. Malaria DALYs averted have also doubled. In, Malaria accounted for 68% of DALYs averted with the distribution of LLINs in Zimbabwe, South Sudan, Mali and ACTs in Congo-Kinshasa, Mali, and Nigeria. By far, our biggest CYP producers are Nigeria, Kenya, Pakistan, Tanzania, and South Africa; total of 53% of YTD CYPs and each accounted for > 1 million CYPs, see page 5. PSI PROGRESS ON SCALE SP to date SP Target % SP Target 5,029,385 44,186,471 41% 120,479,675 198,700,000 60.6% CYPs 1,559,152 16,001,809-15% 59,560,032 105,600,000 56.4% PSI Health Relevance 24.91% PSI Burden 2.25% PSI PROGRESS TOWARD STRATEGIC PLAN (SP) TARGETS IN DALYS AVERTED AND CYPS PSI 2014 Target: 25% increase in DALYs averted relative to 2007-2011 Target: 30% increase in CYPs relative to 2007-2011 Million ion DALYs averted 200 150 100 50-2007-2011 Baseline (158.9 million DALYs averted) 2012-2016 Performance (120.5 million DALYs averted) Million ion CYPs Provided 120 100 80 60 40 2012-2016 SP Target 20 (198.7 million DALYs averted) - PSI REGIONAL AND HEALTH AREA PERFORMANCE Region 2007-2011 2012-2016 YTD % of 2014 Program Target* CYPs Provided YTD 2007-2011 Baseline (81.3 million CYPs) Strategic Plan Time Elapsed 56.7% (34/60 months) 2012-2016 Performance (59.6 million CYPs) 2012-2016 SP Target (105.6 million CYPs) % of 2014 Program Target* West & Central Africa 2,420,778 24,540,977 121% 118% 516,607 4,139,413-19% 71% East Africa 1,008,322 9,831,191-5% 96% 286,172 4,603,434 32% 109% Southern Africa 1,412,431 8,125,142 16% 80% 310,976 2,968,524 6% 82% Latin America & Caribbean 16,085 141,003 6% 82% 74,971 655,900 9% 81% Asia & Eastern Europe 171,768 1,548,158-42% 46% 370,426 3,634,537-47% 45% TOTAL 5,029,385 44,186,471 41% 99% 1,559,152 16,001,809-15% 71% Health Burden Country with Program YTD Burden as % of PSI Global HIV, STD, Hepatitis B&C, Opioid Use 929,492 9,084,996 4% 51 of 53 8.84% 6.81% Tuberculosis 13,307 120,680-1% 9 of 53 0.35% 2.66% Reproductive Health 592,338 6,435,769-12% 52 of 53 4.63% 8.14% Malaria 3,435,844 27,692,087 29 of 53 21.97% 5.43% Diarrhea Diseases 31,965 453,206 12% 29 of 53 0.65% 5.25% Nutritional Deficiencies 17 243-32% 6 of 53 0.00% 2.33% Respiratory Infections 26,421 399,490-54% 5 of 53 0.52% 5.95% Health areas not targeted by PSI 63.41% TOTAL 5,029,385 44,186,471 41% 2.25% * 2014 program targets: 44,748,981 DALYs averted; we should be at 83% in. 2007-2011 2012-2016 CYPs Provided IMPACT DASHBOARD OCTOBER 2014 1
PSI PROGRESS ON RELEVANCE 2014 2016 SP Target Health Relevance 24.91% 42% FP Method Mix* 54.7% (29 of 53)** 75% *% platforms offering 4 or more FP modern methods with at least one long-term method (LTM), ** excluded C.A.R., China, Cote d'ivoire (AIMAS), Mexico, and Romania PSI RELEVANCE: 2010 Global Burden of Disease < Expansion & Innovation > 90% 80% 70% 60% 50% 40% 30% Current works 20% 10% 0% PSI Global Innovation in Other Health Areas: % disease burden not targeted by PSI Notes: started reporting in this period Botswana (added burden from malaria - LLIN distribution) Belize added OC and met the target in this period. DRC and Mozambique added EC. Expansion: % disease burden targeted by existing PSI products/services plus cervical cancer, diabetes mellitus, and high blood pressure, not in use by country platform Health Relevance: % disease burden targeted by current country platform products and services Burden : % DALYs averted by PSI in 2014 as proportion of 2010 Global Burden of Disease in DALYs 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Mozambique Zimbabwe Cameroon Nigeria Zambia Swaziland Madagascar Tanzania South Africa Malawi Uganda Mali Côte d'ivoire Lesotho DRC Botswana Kenya Guinea Benin Rwanda South Sudan Angola Myanmar Burundi Namibia Senegal Togo Liberia Caribbean Pakistan India Belize Cambodia Ethiopia PNG Laos Thailand Dom Rep Guatemala Honduras Viet Nam Panama Nicaragua Tajikistan Paraguay El Salvador Kyrgyzstan yzstan Nepal Haiti Kazakhstan Costa Rica Russia PSI FP Method Mix: classified by modern method mix. FP method mix targets 4 methods + 1 long-term method (LTM) 4 or more modern methods + 1 LTM 4 or more modern methods + 1 LTM 2 modern methods Congo-Kinshasa Ethiopia Papua New Guinea Madagascar Rwanda Somaliland Nigeria El Salvador South Africa Guatemala Nicaragua Swaziland Pakistan Belize Thailand Benin Haiti 1 short-term method Malawi India Botswana Mali Laos Costa Rica Mozambique Liberia Cote d'ivoire Myanmar 3 modern methods Honduras Tanzania Dominican Republic Kazakhstan Togo Nepal Panama Zimbabwe Guinea South Sudan Cambodia Paraguay Tajikistan Cameroon Senegal Vietnam Uganda 2 modern methods no FP method provided Zambia Angola Russia Caribbean Kyrgyzstan Burundi Lesotho Kenya Namibia number of long-term methods including implants, IUDs and male/female sterilization number of short-term methods including male condom, female condom, cycle beads, EC, injectables and OC IMPACT DASHBOARD OCTOBER 2014 2
COUNTRIES BY YTD 2014 DALYS AVERTED 2014 DALYs % of 2014 DALYs Health Relevance % Congo-Kinshasa 785,207 11,232,036 1008% 149% 36.02% 20,137,582 16.7% Nigeria 648,773 10,561,098 47% 109% 44.18% 25,948,794 21.5% Zimbabwe 956,367 2,837,865 54% 76% 45.67% 6,276,042 5.2% South Sudan 459,175 2,386,752-33% 114% 31.99% 8,984,762 7.5% South Africa 239,870 2,001,085 2% 82% 42.59% 6,558,159 5.4% Mali 884,475 1,830,297 151% 72% 40.55% 4,653,614 3.9% Uganda 201,922 1,758,708 68% 102% 40.64% 3,917,218 3.3% Kenya 108,029 1,564,417 78% 129% 35.38% 3,703,580 3.1% Zambia 0 1,353,497-14% 62% 44.16% 5,100,592 4.2% Tanzania 57,063 1,238,378-13% 75% 42.64% 4,032,638 3.3% Mozambique 57,702 1,075,693-29% 77% 48.88% 4,005,265 3.3% Madagascar 78,478 1,027,830 13% 94% 42.82% 4,372,065 3.6% Malawi 57,365 672,255-45% 76% 41.95% 3,796,581 3.2% Pakistan 28,313 603,008-44% 44% 19.82% 2,644,188 2.2% Angola 32,923 496,538 238% 129% 31.42% 1,021,425 0.8% Cameroon 66,038 454,773 36% 92% 44.69% 1,322,463 1.1% India 74,673 402,001-51% 35% 19.34% 2,729,302 2.3% Lesotho 36,737 388,586 46% 154% 37.85% 949,371 0.8% Myanmar 38,858 329,386-28% 69% 31.24% 1,319,561 1.1% Ethiopia 0 284,049-9% 68% 16.37% 1,022,564 0.8% Swaziland 10,771 257,406 24% 88% 43.23% 748,216 0.6% Botswana 83,967 213,817 194% 316% 35.76% 398,199 0.3% Benin 13,532 183,850 12% 86% 32.62% 591,383 0.5% Rwanda 6,436 165,914 3% 71% 32.02% 662,640 0.6% Burundi 25,597 165,819 33% 93% 30.09% 402,846 0.3% Guinea 8,489 131,200-89% 82% 32.89% 1,529,581 1.3% Cambodia 16,882 128,029-34% 63% 18.83% 706,052 0.6% Togo 6,150 70,066-11% 54% 28.40% 260,382 0.2% Senegal 5,219 53,127 29% 68% 29.30% 119,547 0.1% Namibia 6,242 45,057-67% 53% 29.56% 210,331 0.2% Guatemala 3,670 40,670 19% 83% 8.87% 130,597 0.1% Haiti 4,074 34,427-2% 76% 5.01% 166,221 0.1% Dominican Republic 4,634 28,979 3% 87% 9.06% 93,443 0.1% Somaliland 2,110 22,668 16% 84% NA 63,211 0.1% Viet Nam 4,394 19,809-42% 82% 8.17% 87,486 0.1% Cote d'ivoire 1,157 17,544-26% 76% 38.99% 583,226 0.5% Laos 3,379 14,929 33% 95% 13.47% 42,199 0.0% Thailand 4,166 14,516-6% 85% 9.16% 41,363 0.0% Nepal 390 12,716-75% 19% 5.57% 146,996 0.1% Tajikistan 94 12,542 42% 103% 7.48% 28,668 0.0% Papua New Guinea 598 8,231 39% 142% 13.73% 24,911 0.0% Panama 511 7,447 29% 104% 7.91% 20,284 0.0% Liberia 1,738 6,986 50% 78% 21.35% 18,808 0.0% Paraguay 754 6,956 4% 78% 7.00% 22,560 0.0% El Salvador 807 6,613 7% 87% 6.87% 25,037 0.0% Honduras 733 6,319-4% 78% 8.33% 21,182 0.0% Nicaragua 540 5,818-1% 72% 7.58% 21,821 0.0% Kazakhstan 16 2,952 95% 3.79% 15,271 0.0% Belize 158 1,715 30% 88% 19.06% 5,433 0.0% Caribbean 111 1,182 109% 71% 20.35% 4,197 0.0% Costa Rica 92 879-2% 70% 3.06% 3,037 0.0% Kyrgyzstan 5 38-40% 6.49% 16,257 0.0% Russia 0 0 NA NA 0.00% 782 0.0% PSI GLOBAL 5,029,385 44,186,471 41% 99% 24.91% 120,479,675 * 2014 program targets: 44,748,981 DALYs averted; we should be at 83% in. 11 Company 158** 84,045 956,796 7% NA NA 2,680,389 2.2% **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD OCTOBER 2014 3
PSI PRODUCTS & SERVICES BY YTD 2014 DALYS AVERTED 0% Products / Services 2014 DALYs % of 2014 DALYs # Distributed Reporting 2014 CYPs LLIN 1,578,896 18,549,495 161% 119% 27,895,365 24 Malaria PPT (ACT) 1,856,890 9,135,580 37% 111% 15,801,347 12 Condom 675,043 6,506,736-10% 69% 690,586,554 42 5,754,888 Free Condom 241,089 2,561,593 15% 104% 203,085,428 30 1,692,379 Male Circumcision 69,485 1,123,378 10% 87% 311,534 9 Basic Care Package 156,324 1,060,444 56% 96% 21,446,505 2 OC 83,220 728,511-28% 74% 29,548,003 32 1,969,867 Injectable 3 52,824 616,539-7% 77% 6,160,612 27 1,540,153 IUD 10 Insertion 52,280 612,556 2% 108% 287,336 22 1,321,745 HIV Counseling and Testing 35,415 479,690-11% 74% 1,656,916 30 Implant 5 Insertion 35,826 430,849 30% 208% 224,080 17 851,504 Pneumonia PPT 26,421 399,490-54% 684,651 5 Implant 3 Distribution 15,358 265,499 1285% 901% 238,979 6 597,448 IUD 10 Distribution 28,131 261,985-21% 51% 103,274 23 475,060 IUD 5 Insertion 1,184 174,213-19% 1074% 142,959 3 471,765 Diarrhea Treatment Kit 10,841 168,075 26% 69% 2,519,965 11 IUD 5 Distribution 9,414 164,627-71% 23% 175,530 5 579,250 ORS 10,461 122,455 73% 123% 3,717,821 9 TB DOTS 13,307 120,680-1% 85% 20,344 4 Safe Water Solution 7,089 114,344-31% 68% 8,224,260 13 Female Condom 15,622 108,891 25% 111% 8,457,202 19 70,477 Injectable 2 10,430 95,606-5% 56% 1,198,804 4 199,801 Emergency Contraception 3,416 47,215-1% 46% 2,555,523 12 127,776 Implant 3 Insertion 3,340 45,408 82% 113% 31,830 6 79,575 SDM (Cycle Beads) 2,270 42,872 4% 72% 58,721 8 88,082 Implant 5 Distribution 9,999 41,727-72% 14% 23,966 21 91,071 Needle & Syringe 4,743 29,263 137% 91% 3,681,906 4 Water Treatment Tablets 1,725 27,343 9% 83% 55,166,881 17 STI Kit 4,290 24,554 137% 517,162 6 Free Female Condom 1,652 21,414-32% 87% 1,595,506 13 13,296 Misoprostol for PAC (Oral) 5,896 20,526-2% 64% 1,187,785 5 Zinc 1,194 13,633 449% 360% 1,185,213 5 Tubal Ligation 1,036 12,638-35% 21% 5,750 2 57,500 Medication Abortion 1,157 12,457-11% 75% 398,046 3 Naloxone 0 7,912-10% 80% 5,813 2 Early Infant MC 819 6,787-39% 46% 928 1 PUR 655 5,999-21% 95% 38,736,175 10 Injectable 1 135 4,285-24% 53% 194,549 4 14,965 Clean Delivery Kit 463 3,446-24% 67% 48,494 5 Malaria PPT (Non-ACT) 0 3,426-23% 60% 40,200 1 Retreatment IconMaxx 0 3,243-94% NA 21,519 1 Implant 4 Insertion 26 3,241 72% 13% 2,491 3 7,971 Misoprostol for PPH 449 2,977 67% 270% 643,126 3 Skilled Birth Attendance (Facility Deliv 333 2,616 499% NA 11,258 1 LifeStraw 1,357 917% 1020% 7,843 1 Antiretroviral Treatment (Patient-mont 92 940 27% 47% 1,916 1 Cervical Cancer-VIA/PAP & Cryothe 52 543 223% 46% 1,823 8 IPTp2 59 343 348% 1% 8,080 1 Multivitamin 17 243 16% 81% 2,185,680 2 Vasectomy 18 240 1913% 73% 161 1 1,610 Implant 4 Distribution 1-1,410-197% -180% -1,366 1 (4,371) Iron Folic Acid Tablet 0 0 - NA 0 Malaria RDK 0 0 NA NA 5,152,834 11 Micronutrient Powder 0 0 NA NA 1,927,420 3 PSI GLOBAL 5,029,385 44,186,471 41% 99% 16,001,809 * 2014 program targets: 44,748,981 DALYs averted; we should be at 83% in. IMPACT DASHBOARD OCTOBER 2014 4
COUNTRIES BY YTD 2014 CYPS PROVIDED ## 2014 CYPs CYPs % of 2014 CYPs FP Method Mix CYPs Provided % of CYPs Provided Nigeria 295,292 2,806,160 7% 75% 9,254,258 15.5% Kenya 125,508 1,870,510 114% 159% 3,895,854 6.5% Pakistan 72,314 1,653,652-46% 42% 7,390,190 12.4% Tanzania 62,867 1,147,752-19% 75% 3,999,880 6.7% South Africa 130,268 1,061,311 0% 81% 3,524,648 5.9% India 176,473 947,690-59% 36% 7,161,728 12.0% Madagascar 84,701 856,382 10% 92% 2,807,183 4.7% Uganda 53,354 854,129 67% 142% 2,092,753 3.5% Cambodia 39,076 491,161-12% 62% 2,025,531 3.4% Myanmar 56,334 436,896-32% 80% 1,735,448 2.9% Mali 70,551 354,531-58% 58% 1,546,855 2.6% Zambia 352,199-23% 51% 1,499,384 2.5% Cameroon 86,882 347,058 39% 85% 975,265 1.6% Zimbabwe 31,772 330,295 34% 79% 901,782 1.5% Benin 17,511 233,022 5% 88% 761,245 1.3% Ethiopia 0 202,103-10% 69% 721,571 1.2% Guatemala 17,310 199,393 26% 83% 628,208 1.1% Malawi 15,990 182,686 22% 132% 459,783 0.8% Lesotho 17,216 172,418 53% 168% 419,812 0.7% Mozambique 18,696 163,177 18% 63% 502,934 0.8% Congo-Kinshasa 22,898 129,633-73% 32% 1,438,574 2.4% Dominican Republic 18,434 115,617 3% 87% 371,839 0.6% Botswana 42,862 109,145 194% 316% 203,265 0.3% Guinea 7,390 105,701 2% 72% 408,949 0.7% Haiti 12,959 103,956 1% 74% 336,219 0.6% Rwanda 3,833 99,009 3% 70% 345,543 0.6% Togo 7,165 86,247-44% 56% 432,761 0.7% Paraguay 7,524 69,890 4% 79% 226,241 0.4% Senegal 7,826 65,636-12% 60% 212,099 0.4% Swaziland 720 61,954 45% 109% 169,315 0.3% Laos 20,788 56,040 44% 102% 150,804 0.3% Nicaragua 4,947 54,086-1% 70% 205,514 0.3% El Salvador 7,466 44,868 5% 93% 191,083 0.3% Burundi 3,940 42,737 20% 76% 104,717 0.2% Angola 1,730 34,543 28% 95% 136,571 0.2% Panama 2,089 30,027 29% 104% 81,688 0.1% Nepal 281 28,349-81% 14% 422,603 0.7% Namibia 3,437 24,821-66% 54% 114,768 0.2% Honduras 2,886 24,806-4% 78% 85,483 0.1% Thailand 4,322 12,200-3% 97% 32,649 0.1% Costa Rica 864 7,740-8% 65% 27,564 0.0% Cote d'ivoire 746 5,974-34% 142% 17,720 0.0% Liberia 346 5,452 40% 59% 16,492 0.0% South Sudan 0 4,452-79% NA 67,078 0.1% Tajikistan 85 4,087 10% 65% 10,297 0.0% Papua New Guinea 688 4,064 3% 88% 18,593 0.0% Caribbean 314 3,700 101% 69% 14,929 0.0% Somaliland 253 2,336 16% 89% 7,310 0.0% Belize 178 1,816 27% 92% 5,943 0.0% Kazakhstan 48 232-42% 116% 811 0.0% Kyrgyzstan 17 122-99% 98% 37,969 0.1% Viet Nam 0 46-18% 169,172 0.3% Russia 0 0 NA NA 0 0.0% PSI GLOBAL 1,559,152 16,001,809-15% 55% 59,560,032 * 2014 program targets: 22,655,582 CYPs; we should be at 83% in. Company 158** 48,453 548,368 7% NA 1,540,193 2.6% **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD OCTOBER 2014 5